Gide advises Guerbet, a pioneer in the field of contrast agents for medical imaging, on the acquisition of US leading specialty biopharmaceutical company Mallinckrodt’s Contrast Media and Delivery Systems business (CMDS).
Guerbet is acquiring 100% of the CMDS business, present in nearly 50 countries. The transaction is valued at USD 270 million, and shall be paid in cash and debt financed. It concerns the purchase of companies including production sites, intellectual property rights and distribution subsidiaries in various geographical zones.
The transaction is subject to regulatory approvals and other customary closing conditions, and is expected to close in the next few months.
The Gide team advising Guerbet was comprised of Pierre-Antoine Dubecq (partner), David-James Sebag (partner), Matthias Grolier and Pierre-Emmanuel Sirgue on M&A aspects; François Vergne (partner) on employment aspects; Christian Nouel (partner) on tax aspects; Antoine Tézenas du Montcel (partner) on stock exchange aspects; Jean-Hyacinthe de Mitry on intellectual property aspects; Eric Cartier-Millon (partner), Thomas Binet (counsel) and Anne Moriceau on financing aspects; Dimitri Dimitrov (partner) and Charles Terdjman on anti-trust aspects.